medline.ch Gastroenterologie Magen-Darm Neoplasie

	Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancer. Oncologist Ota K, Uemura M, Tanida T, Nakata K, Kudo T, Kagawa Y, Haraguchi N, Minami S, Matsuura Y, Ota H, Hiraki M, Yasui M, Takahashi H, Iwamoto K, Nishida N, Hata T, Nishizawa Y, Fukunaga M, Komori T, Takahashi Y, Tokuyama S, Tamagawa H, Naito A, Yoshihara T, Suzuki R, Sugimoto S, Miyake M, Takiguchi N, Tei M, Tamai K, Fukada A, Ogino T, Miyoshi N, Satoh T, Yamamoto H, Murata K, Doki Y, Eguchi H. PMID: 41766359 [PubMed - as supplied by publisher]
	Specialized healthcare diagnostic events within one year preceding colorectal cancer diagnosis. Acta Oncol Hermiö E, Toikkanen SE, Pylkkänen LH, Järvelin J, Pitkäniemi JM, Malila NK, Seppä KJ. PMID: 41766225 [PubMed - in process]
	Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary. Future Oncol Chen LT, Kang YK, Ryu MH, Oh DY, Oh SC, Rha SY, Lee KW, Omori T, Shitara K, Sakuramoto S, Chung IJ, Yamaguchi K, Kato K, Sym SJ, Kadowaki S, Tsuji K, Chen JS, Bai LY, Oh SY, Choda Y, Yasui H, Takeuchi K, Hirashima Y, Hagihara S, Boku N. PMID: 41766168 [PubMed - as supplied by publisher]
	First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients. Cancer Biol Med Zhao C, Ye S, Chen M, Qian J, Xu J. PMID: 41766111 [PubMed - as supplied by publisher]
	Key molecular mechanisms and regulatory networks in colorectal cancer liver metastasis. Biol Proced Online Zhang Z, Ni Y, Wang J, Tian J, Liu L, Hao S. PMID: 41765876 [PubMed - as supplied by publisher]
	CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study. Acad Radiol Shkurti J, Groot Lipman KBW, Tissier RLM, Chupetlovska K, Pooch EHP, van Dijk-de Haan MC, Pijl MEJ, Taveira MO, Huige JCBM, Gielens MMP, Tonino BAR, van Rooij SBT, Berenschot DS, Coolen L, Beets-Tan RGH, Nederend J. PMID: 41765703 [PubMed - as supplied by publisher]
	Geographical Disparities in Faecal Immunochemical Test-Based Colorectal Cancer Screening Participation and Positivity Rates: A Systematic Review and Meta-Analysis. Health Promot J Austr Azanaw MM, Symonds EL, Laven-Law G, Belay WS, Aftab S, Ahmed MB, Wassie MM. PMID: 41765011 [PubMed - in process]
	EASDnet: Empowering human-centered evidence-based medicine through an evidence and attention-based spatial disparity network for discriminative colorectal cancer histopathological screening and attribution. Pathol Res Pract Zheng S, Bi S. PMID: 41764810 [PubMed - as supplied by publisher]
	The Diagnostic and Prognostic Potential of Serum Taurine and PUMA in Staging Colorectal Cancer Patients. Recent Pat Biotechnol Elashry MA, Samir S, Elrefaiy M, Hammam O, Abu-Taleb H, Ossama Y, Elmeligy HA. PMID: 41764612 [PubMed - as supplied by publisher]
	TEAD4 Identified as a Potential Biomarker for Gastric Cancer Via Genes Associated with Liquid-Liquid Phase Separation. Curr Protein Pept Sci Liu J, Zhang J, Gong A. PMID: 41764605 [PubMed - as supplied by publisher]
	Exploring the optimal follow-up time for resectable colorectal cancer patients: a multicenter, five-year longitudinal cohort study. Sci Rep Kang B, Qiao Y, Wang Y, Li Y, Hu B, Zhang Z, Wang Q, Zhu J, Li J. PMID: 41764294 [PubMed - as supplied by publisher]
	Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluation. J Med Econ Forbes SP, Yay Donderici E, Zhang N, Raymond VM, Das AK, Liang PS. PMID: 41764032 [PubMed - in process]
	Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study. Clin Colorectal Cancer Victoria Ruiz I, Uboha NV, Jamal R, Mejía FC, Ahumada M, Im SA, Gomez-Roca C, Shapira-Frommer R, Perets R, Yañez E, Dutcus C, Okpara CE, Ghori R, Jin F, Groisberg R, Castanon E. PMID: 41763955 [PubMed - as supplied by publisher]
	Combination of PD-1 blockade and neoadjuvant chemoradiotherapy benefits pMMR/MSS patients with locally advance rectal cancer: A phase 2 clinical trial. Drug Resist Updat Yang Z, Xu Z, Sun L, Zheng J, Han J, Li A, Liu G, Sun Y, Zhang J, Chen G, Xu R, Zhang C, Gao J, Bai Z, Deng W, Yao H, Zhang Z. PMID: 41763164 [PubMed - as supplied by publisher]
	Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review. Cancer Treat Rev Siena S, Chalabi M, Goodwin R, Osterlund P, Penault-Llorca F, Sartore-Bianchi A, Starling N, Stintzing S, Tabernero J. PMID: 41763144 [PubMed - as supplied by publisher]
	Assessing Concordance of Cancer Registry Data and Electronic Health Record Data in Metastatic Cancer: a Cohort Study of Patients with Colorectal Liver Metastasis in a U.S. Integrated Health System. Cancer Epidemiol Brauer DG, Sekiya A, Vobugari N, Prakash A, Ozed-Williams B, Ecker BL, Ankeny JS, Jensen EH, Marmor S. PMID: 41763113 [PubMed - as supplied by publisher]
	Effect of whole-course nutrition management on skeletal muscle mass in patients with gastric cancer undergoing neoadjuvant treatment. Eur J Surg Oncol Liu C, Huang H, Liu J, Cao C, Chen W, Yu J. PMID: 41763089 [PubMed - as supplied by publisher]
	Association of cancer on coronary atherosclerotic burden and plaque rupture: Insights from the BRAVADO study. Atherosclerosis Seleme VB, da Silva Costa IBS, Pileggi B, de Barros Branco CE, Rizk SI, de Medeiros Lopes MAAA, Campanha Borges DC, Campos RN, de Brito FS, Abdalla Sanches JM, Godinho RR, Esper RB, Faillace B, Precoma DB, Ribeiro MH, Seabra-Garcez JD, Nunes Ferreira AF, Kalil Filho R, Abizaid A, Hajjar LA, Campos CM. PMID: 41763067 [PubMed - as supplied by publisher]
	From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. Transl Oncol Hamed NW, Elbeljihy HS, Hussin SA, Fouda RM, Oy EK, W Magar R. PMID: 41762538 [PubMed - as supplied by publisher]
	Real-World Evaluation of the Efficacy of Third-Line Treatment Regimens for Advanced Gastric Cancer: A Single-Center Retrospective Study. Br J Hosp Med (Lond) Zhou X, Yu S, Zhu C, Liu T. PMID: 41762081 [PubMed - in process]

Artikel 1 - 20 / 236818

Seite 1 von 11841



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung